These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 32311566

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. A new prognostic score for disease progression and mortality in patients with newly diagnosed primary CNS lymphoma.
    Liu CJ, Lin SY, Yang CF, Yeh CM, Kuan AS, Wang HY, Tsai CK, Gau JP, Hsiao LT, Chen PM, Liu YC, Hong YC, Ko PS, Liu JH, Lin CH.
    Cancer Med; 2020 Mar; 9(6):2134-2145. PubMed ID: 32011103
    [Abstract] [Full Text] [Related]

  • 23. [Clinical and prognostic analysis of 30 cases of primary central nervous system lymphoma].
    She C, Tan L, Li P, Ma L, Li W.
    Zhonghua Xue Ye Xue Za Zhi; 2015 Apr; 36(4):282-5. PubMed ID: 25916286
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Optimizing Surgical Outcomes for Intracranial Epidermoid Tumors: A Retrospective Analysis of Clinical Predictors, Surgical Decisions, and Patient Clustering.
    Delgardo MW, Teasley DE, Tang AJ, Izima C, Peet BM, Pascual-Leone A, Reeves G, Youngerman BE, Connolly ES, McKhann GM, Bruce JN, Feldstein NA, Canoll P, Sisti MB.
    World Neurosurg; 2024 Oct; 190():e931-e938. PubMed ID: 39147022
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Prognostic factors and treatment options for paediatric ependymomas.
    Vaidya K, Smee R, Williams JR.
    J Clin Neurosci; 2012 Sep; 19(9):1228-35. PubMed ID: 22840355
    [Abstract] [Full Text] [Related]

  • 28. Efficacy of the Nordic and the MSKCC chemotherapy protocols on the overall and progression-free survival in intracranial PCNSL.
    Da Broi M, Jahr G, Beiske K, Holte H, Meling TR.
    Blood Cells Mol Dis; 2018 Nov; 73():25-32. PubMed ID: 30217760
    [Abstract] [Full Text] [Related]

  • 29. Cytoreductive Surgery for Primary Central Nervous System Lymphoma: Is it time to consider extent of resection?
    Singhal S, Antoniou E, Kwan E, Gregory G, Lai LT.
    J Clin Neurosci; 2022 Dec; 106():110-116. PubMed ID: 36274297
    [Abstract] [Full Text] [Related]

  • 30. The role of surgical management in primary small bowel lymphoma: A single-center experience.
    Hong YW, Kuo IM, Liu YY, Yeh TS.
    Eur J Surg Oncol; 2017 Oct; 43(10):1886-1893. PubMed ID: 28751057
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Characteristics and Outcomes of Primary Central Nervous System Lymphoma: A Retrospective Study of 91 Cases in a Chinese Population.
    Mao C, Chen F, Li Y, Jiang X, Liu S, Guo H, Huang L, Wei X, Liang Z, Li W, Tang K.
    World Neurosurg; 2019 Mar; 123():e15-e24. PubMed ID: 30326304
    [Abstract] [Full Text] [Related]

  • 33. Prognostic factors for primary central nervous system lymphomas treated with high-dose methotrexate-based chemo-radiotherapy.
    Lee J, Shishido-Hara Y, Suzuki K, Shimizu S, Kobayashi K, Kamma H, Shiokawa Y, Nagane M.
    Jpn J Clin Oncol; 2017 Oct 01; 47(10):925-934. PubMed ID: 28981733
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Pretreatment Hemoglobin as an Independent Prognostic Factor in Primary Central Nervous System Lymphomas.
    Le M, Garcilazo Y, Ibáñez-Juliá MJ, Younan N, Royer-Perron L, Benazra M, Mokhtari K, Houillier C, Hoang-Xuan K, Alentorn A.
    Oncologist; 2019 Sep 01; 24(9):e898-e904. PubMed ID: 30867243
    [Abstract] [Full Text] [Related]

  • 38. TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy.
    Munch-Petersen HD, Asmar F, Dimopoulos K, Areškevičiūtė A, Brown P, Girkov MS, Pedersen A, Sjö LD, Heegaard S, Broholm H, Kristensen LS, Ralfkiaer E, Grønbæk K.
    Acta Neuropathol Commun; 2016 Apr 22; 4():40. PubMed ID: 27101868
    [Abstract] [Full Text] [Related]

  • 39. Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry.
    Mocikova H, Pytlik R, Sykorova A, Janikova A, Prochazka V, Vokurka S, Berkova A, Belada D, Campr V, Buresova L, Trneny M, Czech Lymphoma Study Group.
    Leuk Lymphoma; 2016 Dec 22; 57(12):2777-2783. PubMed ID: 27087066
    [Abstract] [Full Text] [Related]

  • 40. [Clinical characteristics and prognosis of 49 newly diagnosed primary central nervous system diffuse large B-cell lymphoma].
    Song J, Liu H, Shen HL, Yue LZ, Yang XJ, Song WJ, Sun CY, Yu SZ, Ding K, Wang YH, Li LJ, Yu H, Shao YY, Wang CM, Yue SY, Fu R.
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov 14; 42(11):917-922. PubMed ID: 35045653
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.